European Union officials said a proposal to reform the EU pharmaceutical legislation will go a long way towards providing equal access to new medicines, yet the proposal faced pushback from representatives of pharmaceutical companies who argued that shortening the marketing exclusivity periods for new drugs will hurt innovation and stymie clinical research in the region.
Both regulators and industry weighed in on the pharmaceutical reform proposal during a session at DIA Europe on 12 March.
In April 2023, the European Commission published its proposals to reform the EU’s medicines regulations; the first such reform in 20 years. (RELATED: EU releases draft legislation that will reshape pharma regulation, Regulatory Focus 25 August 2023)…
